Group One Trading’s PMV Pharmaceuticals PMVP Stock Holding History

Group One Trading’s Portfolio PMVP Stock Details PMVP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7,900	Closed	-$8.37K	–	8977
2025 Q2	$8.37K	Sell	7,900 -3,900	-33%	-$3.83K	﹤0.01%	6824
2025 Q1	$12.9K	Hold	11,800	–	–	﹤0.01%	6103
2024 Q4	$17.8K	Sell	11,800 -100	-0.8%	-$158	﹤0.01%	5767
2024 Q3	$17.7K	Sell	11,900 -100	-0.8%	-$155	﹤0.01%	5290
2024 Q2	$19.4K	Hold	12,000	–	–	﹤0.01%	5254
2024 Q1	$20.4K	Buy	+12,000	New	+$22.4K	﹤0.01%	5396
2023 Q4	–	Sell	-900	Closed	-$5.53K	–	8012
2023 Q3	$5.53K	Buy	+900	New	+$6.19K	﹤0.01%	6652
2022 Q3	–	Sell	-4,600	Closed	-$66K	–	8073
2022 Q2	$66K	Buy	+4,600	New	+$66.9K	﹤0.01%	5332

Other funds holding PMVP

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Group One Trading's PMVP Position: Q2 2026 in Review

Group One Trading held its PMV Pharmaceuticals (PMVP) position steady in Q2 2026 at 90 shares worth $121. The position accounts for ﹤0.01% of the portfolio, ranked #7397.

Group One Trading first reported a position in PMVP in Q4 2022 and has held it in 13 quarters since. The position peaked at $72.7K in Q3 2023. 64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

Group One Trading held 90 shares of PMV Pharmaceuticals worth $121 as of Q2 2026.
Group One Trading left its PMV Pharmaceuticals share count unchanged in Q2 2026.
PMV Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #7397 holding.
Group One Trading first reported a position in PMV Pharmaceuticals in Q4 2022 and has held it in 13 quarters since.
Group One Trading's PMV Pharmaceuticals position peaked at $72.7K in Q3 2023.
64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.